Datapoint

Datapoint: Gilead Shores Up Breast Cancer Indication for Trodelvy

The FDA last week granted Gilead Sciences’ Trodelvy full approval for the treatment of triple-negative breast cancer (TNBC) — clearing the drug for use in TNBC patients who have received two or more prior trea...
0 Comments

Datapoint: Biden Administration Pulls Work Requirements in Michigan, Wisconsin

The Biden administration last week nixed Medicaid work requirement approvals in two more states — Michigan and Wisconsin. The news comes just three weeks after Biden’s CMS pulled the controversial Medicaid re...
0 Comments

Datapoint: MVP Health Care, University of Vermont to Launch Co-Branded MA Plan

MVP Health Care last week said it has partnered with The University of Vermont Health Network to launch a co-branded, physician-designed Medicare Advantage (MA) plan in New York and Vermont for the 2022 plan year. T...
0 Comments

Datapoint: Friday Health Plans Scores $160 Million Investment

Startup insurer Friday Health Plans last week said it has accepted $160 million in equity investments led by Vestar Capital Partners and Leadenhall Capital Partners, and will use the funds to expand into new ter...
0 Comments

Datapoint: Fallon Health to Exit Commercial Insurance Market

Worcester, Massachuetts-based insurer Fallon Health last week said it will “shift away” from most commercial product lines as of April 1, citing a renewed focus on Medicare and Medicaid. Fallon currently has ...
0 Comments

Datapoint: Sarclisa to Compete with Darzalex in Multiple Myeloma

The FDA last week approved Sanofi’s Sarclisa (in tandem with Amgen’s Kyprolis and dexamethasone) for the treatment of relapsed or refractory multiple myeloma in patients who have had at least one prior treatme...
0 Comments

Datapoint: Medicaid Enrollment Grows More Than 10% Year-Over-Year

From March 2020 to March 2021, the total U.S. Medicaid population (including managed care plans and traditional fee-for-service coverage) grew 11.1% to 81.9 million lives, according to the latest update to AIS...
0 Comments

Datapoint: Blues Plans Enroll Half of Group Risk Market

Nearly half (47.3%) of the national group commercial risk insurance market is enrolled in a Blue Cross and Blue Shield affiliate plan. Of the 26.2 million group risk lives enrolled in a Blues plan, 20.5% are Ant...
0 Comments

Datapoint: FDA Approves Abecma for Multiple Myeloma

The FDA last week approved Bristol Myers Squibb’s and bluebird bio’s Abecma for the treatment of multiple myeloma in patients who have not responded to at least four previous rounds of treatment. Abecma is t...
0 Comments

Datapoint: Anthem to Acquire Senior Home Management Company

Anthem, Inc. last week unveiled plans to acquire myNEXUS, Inc., “a comprehensive home-based nursing management company for payors,” the insurer said in a press release. The myNEXUS platform is a provider-facin...
0 Comments